Loading...
Loading...
Mathematical datasets, statistical benchmarks, probability, optimization, operations research
3,080 datasets
A 2026 Bayesian network meta-analysis of 9 randomized controlled trials involving 1,760 patients with metastatic or advanced radioiodine-refractory differentiated thyroid cancer. The analysis, authored by Pin Wang and shared on figshare, evaluates the efficacy and safety of targeted therapies, comparing outcomes like progression-free survival, overall survival, and adverse events.
A Bayesian network meta-analysis of 9 randomized controlled trials involving 1,760 patients with metastatic or advanced radioiodine-refractory differentiated thyroid cancer. The analysis, published by Pin Wang on figshare, compares the efficacy and safety of targeted therapies, with primary outcomes including progression-free survival and objective response rate. The dataset was last updated in March 2026.
A systematic review and Bayesian network meta-analysis of 9 randomized controlled trials involving 1,760 patients with metastatic or advanced radioiodine-refractory differentiated thyroid cancer. The analysis, conducted by Pin Wang and published on figshare in 2026, compares the efficacy and safety of targeted therapies like lenvatinib, anlotinib, apatinib, and cabozantinib. Primary outcomes measured include progression-free survival, overall survival, objective response rate, and adverse events.
9 randomized controlled trials involving 1,760 patients with radioiodine-refractory differentiated thyroid cancer were analyzed. The data, compiled by Pin Wang and last updated in March 2026, includes hazard ratios and odds ratios for progression-free survival, overall survival, objective response rate, and adverse events. Results are presented in an Excel file.
A 2026 Bayesian network meta-analysis of 9 randomized controlled trials involving 1,760 patients with metastatic or advanced radioiodine-refractory differentiated thyroid cancer. The dataset, authored by Pin Wang and shared on figshare, compares the efficacy and safety of targeted therapies like lenvatinib, anlotinib, apatinib, and cabozantinib against placebo. It includes results for progression-free survival, overall survival, objective response rate, and adverse events.
9 randomized controlled trials involving 1,760 patients with advanced radioiodine-refractory differentiated thyroid cancer were analyzed. The dataset contains results from a Bayesian network meta-analysis comparing the efficacy and safety of targeted therapies, including lenvatinib, anlotinib, apatinib, and cabozantinib. It was authored by Pin Wang and uploaded to figshare on 2026-03-18.
A 33.0 KB Excel file containing results from a Bayesian network meta-analysis of 9 randomized controlled trials involving 1,760 patients with radioiodine-refractory differentiated thyroid cancer. The analysis, authored by Pin Wang and uploaded to figshare, compares the efficacy and safety of targeted therapies like lenvatinib, anlotinib, apatinib, and cabozantinib, with outcomes including progression-free survival and objective response rate. The dataset was last updated on March 18, 2026.
A systematic review and Bayesian network meta-analysis of 9 randomized controlled trials involving 1,760 patients with metastatic or advanced radioiodine-refractory differentiated thyroid cancer. The dataset, published by Pin Wang on figshare, compares the efficacy and safety of targeted therapies like lenvatinib, anlotinib, apatinib, and cabozantinib based on outcomes including progression-free survival and objective response rate. The analysis was registered with PROSPERO (CRD420251089713) and the dataset was last updated in March 2026.
A Bayesian network meta-analysis comparing the efficacy and safety of targeted therapies for metastatic or advanced radioiodine-refractory differentiated thyroid cancer. The analysis is based on 9 randomized controlled trials involving 1,760 patients, evaluating outcomes including progression-free survival and objective response rate. The dataset was created by Pin Wang and last updated in March 2026.
21 pulse-counting channels and averaged currents from a Cerenkov counter, electron scatter detector, and minimizing ionizing particle counter on the Pioneer 10 spacecraft. The ASCII data set contains 30-minute count rates and currents, spacecraft position and attitude data, and statistical and housekeeping data for mission cruise phases. This data was produced by the National Aeronautics and Space Administration and was last updated on the platform in March 2026.
NASA's Pioneer 11 Trapped Radiation Detector (TRD) dataset contains 30-minute count rates and averaged currents from multiple particle detection instruments. The data includes measurements from a Cerenkov counter, an electron scatter detector, and a minimizing ionizing particle counter, along with spacecraft position and attitude data. All data are for mission cruise phases and not planetary encounters.
5.5 KB of performance metrics for a competing method evaluated on the CMU-MOSEI dataset. The data is provided in an XLS file by author Weiguang Dong and was last updated on April 27, 2026. The dataset is licensed under CC-BY-4.0.
Weiguang Dong published a 9.5 KB Excel file on figshare in April 2026. The dataset appears to contain performance metrics for competing methods evaluated on the RAVDESS (Ryerson Audio-Visual Database of Emotional Speech and Song) dataset. It includes statistical validation results for these methods.
A systematic review and meta-analysis of 17 randomized controlled trials, comprising data from 2,349 pregnant women with diabetes, published from database inception through February 5, 2026. The study compares continuous glucose monitoring (CGM) to standard self-monitoring (SMBG) on neonatal outcomes like NICU admission, LGA, SGA, neonatal hypoglycemia, and hyperbilirubinemia. It was authored by Xiaojun Lai and reports pooled risk ratios with 95% confidence intervals.
A systematic review and meta-analysis of 17 randomized controlled trials, comprising data from 2,349 pregnant women with diabetes, compares continuous glucose monitoring (CGM) to standard blood glucose monitoring. The study, authored by Xiaojun Lai and published in 2026, calculates pooled risk ratios for neonatal outcomes including NICU admission, large for gestational age, and neonatal hypoglycemia.
2,349 pregnant women with diabetes from 17 randomized controlled trials compare continuous glucose monitoring (CGM) to standard self-monitoring (SMBG). The analysis reports pooled risk ratios for outcomes including neonatal intensive care unit admission, large for gestational age, and neonatal hypoglycemia. The meta-analysis was conducted by Xiaojun Lai and published in 2026.
5.5 KB Excel table summarizing statistical tests for publication bias and adjusted mean heritability estimates. The data, authored by Sare Golpasand and last updated in April 2026, likely contains results from applying the trim-and-fill method to traits with no detected heterogeneity. It presents imputed results for potentially missing studies.
5.5 KB Excel file contains statistical performance metrics, likely including means and standard deviations. Author Zhida Lin published the dataset under a CC-BY-4.0 license on figshare in April 2026. The data appears to be a compact summary of results from 30 repeated runs of an experiment or model.
A 5.5 KB XLS file contains power analysis results for the effect sizes of great coaches on Olympic performance. The study by You Liu applies a Change-Point Driven Difference-in-Differences with Decay Model to quantify coaching impacts. It includes specific predictions, such as a 5.3-year half-life for technology-driven interventions and a forecast of 5 medals for the Brazilian swimming team in 2028.
Figure S6D contains ELISpot assay data measuring interferon-gamma responses in mouse splenocytes. The data, published by Luqiang Guo on figshare in April 2026, shows spot counts per million cells for mice immunized with different doses of ANDV-GPC repRNA/LION constructs and stimulated with peptide pools. Statistical analysis was performed using one-way ANOVA with Tukey's test, and results are presented as means with standard deviation.